You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 109 No. 11, November 1983 TABLE OF CONTENTS
  Archives
  •  Online Features
  AMERICAN SOCIETY FOR HEAD AND NECK SURGERY MEETING
 This Article
 •References
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

The Effect of Indomethacin on the Growth of Epidermoid Carcinoma of the Palate in Rats

Andrew Blitzer, DDS, MD; Cheng Chun Huang, PhD

Arch Otolaryngol. 1983;109(11):719-723.


Abstract

• The in vivo effect of indomethacin therapy in head and neck cancer was tested using rats (Fisher 344) with implanted epithelial palatal carcinoma. Indomethacin was then given to half of the rats in their drinking water, starting two weeks after tumor implantation. The animals were then killed at four weeks and the tumor volumes were measured. It was found that four (21%) of the 19 rats were complete responders and eight (42%) of the 19 rats were partial responders. The control group showed increased tumor growth in all animals. The experimental group also demonstrated five (26%) of the 19 regional metastases. No metastases were seen in the control group. Indomethacin seems to inhibit local tumor growth, perhaps through its effects on cellular and humoral immunity and its effects on the host-tissue stroma. It also may increase tumor spread through the regional lymphatics or hematogenously. Further animal studies need to be carried out to determine the effect on cancer on a cellular and biochemical level before using it for treatment of cancer in humans.

(Arch Otolaryngol 1983;109:719-723)



Author Affiliations

From the Department of Otolaryngology, College of Physicians and Surgeons, Columbia University, New York.


Footnotes

Accepted for publication May 11, 1983.

Read before the American Society for Head and Neck Surgery, Palm Springs, Calif, March 11, 1983.

Reprint requests to the Department of Otolaryngology, College of Physicians and Surgeons, Columbia University, 630 W 168th St, New York, NY 10032 (Dr Blitzer).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Prostaglandin Inhibitor and Radiotherapy in Advanced Head and Neck Cancers
Pillsbury et al.
Arch Otolaryngol Head Neck Surg 1986;112:552-553.
ABSTRACT  

Prostaglandins and Other Metabolites of Arachidonic Acid: An Overview for the Otolaryngologist
Poole and Pillsbury
Arch Otolaryngol Head Neck Surg 1985;111:317-321.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1983 American Medical Association. All Rights Reserved.